Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience
Figure 2
Male, 56 years old, with pancreatic NET and multiple liver metastases. 68Ga-DOTATOC PET/CT before therapy (a) and after PRRT (b). The result was a partial response.
